Funded startups/Swift Cardiovascular, Inc.
SC

Swift Cardiovascular, Inc.

SEC filing
Biotechnology · Durham, NC
Form D on EDGAR
Amount raised$810Ksold at filing
Total offering$1.5M$690K still open
Investors in the raise7count reported to the SEC
FiledSep 24, 2026first sale Jan 21, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Jospeh Blakely LongExecutive Officer
Kemal Vincent SchankereliDirector
Howard Vincent KellyDirector
Richard Francis MurphyExecutive Officer
Jeffrey Harold LawsonExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.